nineteen of the allogeneic recipients received methotrexate ( mtx ) and 15 received cyclosporin a ( cya ) as the predominant immunosuppressive agent to minimize graft-versus-host disease ( gvhd ) post transplant .
C0010592
cyclosporin a
C0018133
graft-versus-host disease